Maternus-Kliniken AGHAM:MAK +0.56%41 EV-to-FCF is 17.71 as of Jul. 02, 2026, which is 16% above its 10-year median of 15.25. GuruFocus rates HAM:MAK with a GF Score™ of 41/100 and a GF Value™ of €1.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Maternus-Kliniken AG ranks worse than 50.49% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Maternus-Kliniken AG's Enterprise Value is €197.7 Mil.
Maternus-Kliniken AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €11.2 Mil. Therefore, Maternus-Kliniken AG's EV-to-FCF for today is 17.71.
The historical rank and industry rank for Maternus-Kliniken AG's EV-to-FCF or its related term are showing as below:
HAM:MAK'
s EV-to-FCF Range Over the Past 10 Years
Min: -149.53 Med: 15.25 Max: 100.02
Current: 17.65
During the past 13 years, the highest EV-to-FCF of Maternus-Kliniken AG was 100.02. The lowest was -149.53. And the median was 15.25.
HAM:MAK's EV-to-FCF is ranked worse than 50.49% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.57
vs HAM:MAK: 17.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maternus-Kliniken AG (HAM:MAK) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maternus-Kliniken AG's PE Ratio (TTM) for today is calculated as:
Maternus-Kliniken AG's share price for today is €0.905.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maternus-Kliniken AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Maternus-Kliniken AG EV-to-FCF Related Terms
Maternus-Kliniken AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Maternus-Kliniken AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Maternus-Kliniken AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maternus-Kliniken AG EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Maternus-Kliniken AG's EV-to-FCF falls into.
Maternus-Kliniken AG's current Enterprise Value is €197.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maternus-Kliniken AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €11.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maternus-Kliniken AG (HAM:MAK) has a EV-to-FCF of 17.71 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maternus-Kliniken AG and its competitors. This is 16% above median its historical median of 15.25. According to the industry distribution chart, Maternus-Kliniken AG ranks #205 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 50.5%.
Is Maternus-Kliniken AG's EV-to-FCF too high?
Maternus-Kliniken AG's current EV-to-FCF of 17.71 is 16% above median its 10-year median of 15.25. The Healthcare Providers & Services industry median EV-to-FCF is 17.57. Maternus-Kliniken AG's value of 17.71 is 0.8% above this industry median. Based on the distribution chart, Maternus-Kliniken AG ranks #205 out of 406 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Maternus-Kliniken AG has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maternus-Kliniken AG's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Maternus-Kliniken AG ranks #205 out of 406 companies for EV-to-FCF. This places Maternus-Kliniken AG in the lower half of its industry. The industry median EV-to-FCF is 17.57. Maternus-Kliniken AG's value of 17.71 is 0.8% above this benchmark. While the company's 10-year median is 15.25 vs. the industry median of 17.57, Maternus-Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.57, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maternus-Kliniken AG's current EV-to-FCF of 17.71 is 0.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maternus-Kliniken AG and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maternus-Kliniken AG's current EV-to-FCF is 17.71, which is 16% above median its own 10-year median of 15.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maternus-Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Maternus-Kliniken AG (HAM:MAK) is currently considered Possible Value Trap. The stock's GF Value™ is €1.97, compared to a current price of €0.91 — trading 54.1% below its estimated fair value. The current EV-to-FCF is 17.71, which is 16% above median its 10-year median of 15.25 and 0.8% above the Healthcare Providers & Services industry median of 17.57. Maternus-Kliniken AG's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Maternus-Kliniken AG (HAM:MAK), the current EV-to-FCF is 17.71 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maternus-Kliniken AG (HAM:MAK) Overvalued in 2026?
Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued.
The current stock price of €0.91 is trading 54.1% below its estimated GF Value™ of €1.97.
GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.
Key valuation signals for HAM:MAK:
EV-to-FCF: 17.71 (16% above median its 10-year median of 15.25)
GF Value™: €1.97 vs. price of €0.91 (54.1% below fair value)
Industry Position: 0.8% above the Healthcare Providers & Services median (#205 of 406)
No single metric tells the full story. See the HAM:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:MAK has been successfully added to your 
